Buy or sell Mindstrong stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Mindstrong Stock

Digital Mental Healthcare

Founded

2014

Notable Investors

ARCH Venture Partners

Headquarters

Mountain View CA, US

Total Funding

$160M

About Mindstrong Stock

Mindstrong's patented science and technology was developed by Dr. Dagum, and is based on four years of extensive clinical studies applying machine intelligence to human-computer interactions patterns. Dr. Dagum's work creates, for the first time, a way to objectively and continuously measure brain function day-to-day providing new insight not previously possible with traditional neuropsychological and imaging techniques. Mindstrong products are in clinical trials in numerous partnership projects with payers, providers, academics and the pharmaceutical industry to bring these new tools to bear on answering the most fundamental questions in behavioral health.

Investors

Funding History

June 2017$14.0M
June 2018$15.0M
December 2018$31.0M
May 2020$100M

Management

Chief Executive Officer

Michelle Wagner

Chief Technology Officer

Miguel Alvarado

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Mindstrong or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 250K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo